Yes...March is a big month for clinical trial outcomes
- BARDA Feasibility Trial results for full thickness burns (note American Burns Association Annual Meeting 17th - 20th March)
- CE Mark Burn Trial results (kinda redundant since we have CE Mark Approval...but another catalyst for Eurozone sales I would think)
We know the outcomes from both trials will be positive...at the 1/2 yearly con call PB said something like there is no downside risk from these trials
We should also expect regulatory approvals for Sth Korea and Taiwan soon
PNV - Chart, page-5324
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.05 |
Change
-0.040(1.91%) |
Mkt cap ! $1.414B | |||
| Open | High | Low | Value | Volume |
| $2.10 | $2.14 | $2.04 | $1.879M | 908.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4378 | $2.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.06 | 3000 | 1 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.06 |
Change
-0.040 ( 1.57 %) |
||||
| Open | High | Low | Volume | ||
| $2.11 | $2.14 | $2.04 | 350187 | ||
| Last updated 15.59pm 06/05/2024 ? | |||||
| PNV (ASX) Chart |